Biomarker Research Services Market by Service Type and Therapeutic area - Global Industry Analysis & Forecast to 2027
Published On : June 2022 Pages : 180 Category: Medical Devices Report Code : HC064101
Biomarker Research Services Market by Service Type (Companion Diagnostic Research Services, Biomarker Research Services) Therapeutic area (Neurological Disorders, Cardiovascular Diseases, Oncology, Immunological Diseases, Others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
Biomarkers are cell occasions used to interface a particular ecological contact to a wellbeing result or target ailment. Biomarkers assume a significant job in understanding the advancement of interminable human illnesses and recognizable proof of subgroups that expands hazard for ailment. Biomarkers are widely utilized in every single remedial zone of the drug to analyze a specific infection.
Drivers and Restraints
Increasing incidences of illnesses, for example, cancer, cardiovascular maladies, and neurological infections and rising interest for biomarkers in demonstrative restorative over the globe is a key factor expected to drive the development of the worldwide market over the forecast period. What's more, increasing therapeutic zones of buddy diagnostics in customized medicine is another factor expected to further fuel development of the target market over the forecast period.
Regional Insights
The market in North America is expected to dominate into the worldwide market and is relied upon to continue with its dominance over the forecast period.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Covance, Inc.
- BioIVT
- ReproCELL USA Inc.
- SRI International, Inc.
- Coriell Institute
- Noble Life Sciences, Inc.
- Nordic Bioscience Holding A/S
- PointCross Life Sciences
- Proteome Sciences plc
- ICON Public Limited Company
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Biomarker Research Services Market, By Service Type, Estimates and Forecast, 2017-2027 ($Million)
o Companion Diagnostic Research Services
o Biomarker Research Services
· Biomarker Research Services Market, By Therapeutic area, Estimates and Forecast, 2017-2027 ($Million)
o Neurological Disorders
o Cardiovascular Diseases
o Oncology
o Immunological Diseases
o Others
· Biomarker Research Services Market, By Key Players
o Covance, Inc.
o BioIVT
o ReproCELL USA Inc.
o SRI International, Inc.
o Coriell Institute
o Noble Life Sciences, Inc.
o Nordic Bioscience Holding A/S
o PointCross Life Sciences
o Proteome Sciences plc
o ICON Public Limited Company
· Biomarker Research Services Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Biomarker Research Services Market, By Country
o U.S. Biomarker Research Services Market
o Canada Biomarker Research Services Market
o Mexico Biomarker Research Services Market
o Europe
§ Europe Biomarker Research Services Market, By Country
o Germany Biomarker Research Services Market
o UK Biomarker Research Services Market
o France Biomarker Research Services Market
o Russia Biomarker Research Services Market
o Italy Biomarker Research Services Market
o Rest of Europe Biomarker Research Services Market
o Asia-Pacific
§ Asia-Pacific Biomarker Research Services Market, By Country
o China Biomarker Research Services Market
o Japan Biomarker Research Services Market
o South Korea Biomarker Research Services Market
o India Biomarker Research Services Market
o Southeast Asia Biomarker Research Services Market
o Rest of Asia-Pacific Biomarker Research Services Market
o South America
§ South America Biomarker Research Services Market
o Brazil Biomarker Research Services Market
o Argentina Biomarker Research Services Market
o Columbia Biomarker Research Services Market
o Rest of South America Biomarker Research Services Market
o Middle East and Africa
§ Middle East and Africa Biomarker Research Services Market
o Saudi Arabia Biomarker Research Services Market
o UAE Biomarker Research Services Market
o Egypt Biomarker Research Services Market
o Nigeria Biomarker Research Services Market
o South Africa Biomarker Research Services Market
o Rest of MEA Biomarker Research Services Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Biomarker Research Services Market, By Service Type
5.1. Introduction
5.2. Global Biomarker Research Services Revenue and Market Share by Service Type (2017-2027)
5.2.1. Global Biomarker Research Services Revenue and Revenue Share by Service Type (2017-2027)
5.3. Companion Diagnostic Research Services
5.3.1. Global Companion Diagnostic Research Services Revenue and Growth Rate (2017-2027)
5.4. Biomarker Research Services
5.4.1. Global Biomarker Research Services Revenue and Growth Rate (2017-2027)
6. Biomarker Research Services Market, By Therapeutic Area
6.1. Introduction
6.2. Global Biomarker Research Services Revenue and Market Share by Therapeutic Area (2017-2027)
6.2.1. Global Biomarker Research Services Revenue and Revenue Share by Therapeutic Area (2017-2027)
6.3. Neurological Disorders
6.3.1. Global Neurological Disorders Revenue and Growth Rate (2017-2027)
6.4. Cardiovascular Diseases
6.4.1. Global Cardiovascular Diseases Revenue and Growth Rate (2017-2027)
6.5. Oncology
6.5.1. Global Oncology Revenue and Growth Rate (2017-2027)
6.6. Immunological Diseases
6.6.1. Global Immunological Diseases Revenue and Growth Rate (2017-2027)
6.7. Others
6.7.1. Global Others Revenue and Growth Rate (2017-2027)
7. Biomarker Research Services Market, By Region
7.1. Introduction
7.2. Global Biomarker Research Services Revenue and Market Share by Regions
7.2.1. Global Biomarker Research Services Revenue by Regions (2017-2027)
7.3. North America Biomarker Research Services by Countries
7.3.1. North America Biomarker Research Services Revenue and Growth Rate (2017-2027)
7.3.2. North America Biomarker Research Services Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Biomarker Research Services by Countries
7.4.1. Europe Biomarker Research Services Revenue and Growth Rate (2017-2027)
7.4.2. Europe Biomarker Research Services Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Biomarker Research Services by Countries
7.5.1. Asia-Pacific Biomarker Research Services Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Biomarker Research Services Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Biomarker Research Services by Countries
7.6.1. South America Biomarker Research Services Revenue and Growth Rate (2017-2027)
7.6.2. South America Biomarker Research Services Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Biomarker Research Services by Countries
7.7.1. Middle East and Africa Biomarker Research Services Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Biomarker Research Services Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Covance, Inc.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. BioIVT
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. ReproCELL USA Inc.
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. SRI International, Inc.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Coriell Institute
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Noble Life Sciences, Inc.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Nordic Bioscience Holding A/S
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. PointCross Life Sciences
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Proteome Sciences plc
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. ICON Public Limited Company
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Biomarker Research Services Market Forecast (2017-2027)
9.1. Global Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Biomarker Research Services Market Forecast by Regions (2017-2027)
9.2.1. North America Biomarker Research Services Market Forecast (2017-2027)
9.2.1.1. United States Biomarker Research Services Market Forecast (2017-2027)
9.2.1.2. Canada Biomarker Research Services Market Forecast (2017-2027)
9.2.1.3. Mexico Biomarker Research Services Market Forecast (2017-2027)
9.2.2. Europe Biomarker Research Services Market Forecast (2017-2027)
9.2.2.1. Germany Biomarker Research Services Market Forecast (2017-2027)
9.2.2.2. France Biomarker Research Services Market Forecast (2017-2027)
9.2.2.3. UK Biomarker Research Services Market Forecast (2017-2027)
9.2.2.4. Russia Biomarker Research Services Market Forecast (2017-2027)
9.2.2.5. Italy Biomarker Research Services Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Biomarker Research Services Market Forecast (2017-2027)
9.2.3. Asia-Pacific Biomarker Research Services Market Forecast (2017-2027)
9.2.3.1. China Biomarker Research Services Market Forecast (2017-2027)
9.2.3.2. Japan Biomarker Research Services Market Forecast (2017-2027)
9.2.3.3. Korea Biomarker Research Services Market Forecast (2017-2027)
9.2.3.4. India Biomarker Research Services Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Biomarker Research Services Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Biomarker Research Services Market Forecast (2017-2027)
9.2.4. South America Biomarker Research Services Market Forecast (2017-2027)
9.2.4.1. Brazil Biomarker Research Services Market Forecast (2017-2027)
9.2.4.2. Argentina Biomarker Research Services Market Forecast (2017-2027)
9.2.4.3. Columbia Biomarker Research Services Market Forecast (2017-2027)
9.2.4.4. Rest of South America Biomarker Research Services Market Forecast (2017-2027)
9.2.5. Middle East and Africa Biomarker Research Services Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Biomarker Research Services Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Biomarker Research Services Market Forecast (2017-2027)
9.2.5.3. Egypt Biomarker Research Services Market Forecast (2017-2027)
9.2.5.4. Nigeria Biomarker Research Services Market Forecast (2017-2027)
9.2.5.5. South Africa Biomarker Research Services Market Forecast (2017-2027)
9.2.5.6. Turkey Biomarker Research Services Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Biomarker Research Services Market Forecast (2017-2027)
9.3. Biomarker Research Services Market Forecast by Service Type (2017-2027)
9.3.1. Biomarker Research Services Forecast by Service Type (2017-2027)
9.3.2. Biomarker Research Services Market Share Forecast by Service Type (2017-2027)
9.4. Biomarker Research Services Market Forecast by Therapeutic Area (2017-2027)
9.4.1. Biomarker Research Services Forecast by Therapeutic Area (2017-2027)
9.4.2. Biomarker Research Services Market Share Forecast by Therapeutic Area (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Biomarker Research Services Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Biomarker Research Services Revenue and Revenue Share by Service Type (2017-2018)
Figure Global Companion Diagnostic Research Services Revenue and Growth Rate (2017-2018)
Figure Global Biomarker Research Services Revenue and Growth Rate (2017-2018)
Table Global Biomarker Research Services Revenue and Revenue Share by Therapeutic Area (2017-2018)
Figure Global Neurological Disorders Revenue and Growth Rate (2017-2018)
Figure Global Cardiovascular Diseases Revenue and Growth Rate (2017-2018)
Figure Global Oncology Revenue and Growth Rate (2017-2018)
Figure Global Immunological Diseases Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Biomarker Research Services Revenue by Regions (2017-2018)
Figure North America Biomarker Research Services Growth Rate (2017-2018)
Figure North America Biomarker Research Services Revenue and Growth Rate (2017-2018)
Figure North America Biomarker Research Services by Countries (2017-2018)
Figure North America Biomarker Research Services Revenue (Million USD) by Countries (2017-2018)
Figure United States Biomarker Research Services Growth Rate (2017-2018)
Figure United States Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Biomarker Research Services Growth Rate (2017-2018)
Figure Canada Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Biomarker Research Services Growth Rate (2017-2018)
Figure Mexico Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Biomarker Research Services Growth Rate (2017-2018)
Figure Europe Biomarker Research Services Revenue and Growth Rate (2017-2018)
Figure Europe Biomarker Research Services by Countries (2017-2018)
Figure Europe Biomarker Research Services Revenue (Million USD) by Countries (2017-2018)
Figure Germany Biomarker Research Services Growth Rate (2017-2018)
Figure Germany Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Biomarker Research Services Growth Rate (2017-2018)
Figure France Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Biomarker Research Services Growth Rate (2017-2018)
Figure UK Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Biomarker Research Services Growth Rate (2017-2018)
Figure Russia Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Biomarker Research Services Growth Rate (2017-2018)
Figure Italy Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Biomarker Research Services Growth Rate (2017-2018)
Figure Rest of Europe Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Biomarker Research Services Growth Rate (2017-2018)
Figure Asia-Pacific Biomarker Research Services Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Biomarker Research Services by Countries (2017-2018)
Figure Asia-Pacific Biomarker Research Services Revenue (Million USD) by Countries (2017-2018)
Figure China Biomarker Research Services Growth Rate (2017-2018)
Figure China Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Biomarker Research Services Growth Rate (2017-2018)
Figure Japan Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Biomarker Research Services Growth Rate (2017-2018)
Figure Korea Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Biomarker Research Services Growth Rate (2017-2018)
Figure India Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Biomarker Research Services Growth Rate (2017-2018)
Figure Southeast Asia Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Biomarker Research Services Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Biomarker Research Services Growth Rate (2017-2018)
Figure South America Biomarker Research Services Revenue and Growth Rate (2017-2018)
Figure South America Biomarker Research Services by Countries (2017-2018)
Figure South America Biomarker Research Services Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Biomarker Research Services Growth Rate (2017-2018)
Figure Brazil Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Biomarker Research Services Growth Rate (2017-2018)
Figure Argentina Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Biomarker Research Services Growth Rate (2017-2018)
Figure Columbia Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Biomarker Research Services Growth Rate (2017-2018)
Figure Rest of South America Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Biomarker Research Services Growth Rate (2017-2018)
Figure Middle East and Africa Biomarker Research Services Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Biomarker Research Services by Countries (2017-2018)
Figure Middle East and Africa Biomarker Research Services Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Biomarker Research Services Growth Rate (2017-2018)
Figure Saudi Arabia Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Biomarker Research Services Growth Rate (2017-2018)
Figure United Arab Emirates Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Biomarker Research Services Growth Rate (2017-2018)
Figure Egypt Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Biomarker Research Services Growth Rate (2017-2018)
Figure Nigeria Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Biomarker Research Services Growth Rate (2017-2018)
Figure South Africa Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Biomarker Research Services Growth Rate (2017-2018)
Figure Turkey Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Biomarker Research Services Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Biomarker Research Services Revenue (Millions USD) and Growth Rate (2017-2018)
Table Covance, Inc. Biomarker Research Services Financial Overview
Table BioIVT Biomarker Research Services Financial Overview
Table ReproCELL USA Inc. Biomarker Research Services Financial Overview
Table SRI International, Inc. Biomarker Research Services Financial Overview
Table Coriell Institute Biomarker Research Services Financial Overview
Table Noble Life Sciences, Inc. Biomarker Research Services Financial Overview
Table Nordic Bioscience Holding A/S Biomarker Research Services Financial Overview
Table PointCross Life Sciences Biomarker Research Services Financial Overview
Table Proteome Sciences plc Biomarker Research Services Financial Overview
Table ICON Public Limited Company Biomarker Research Services Financial Overview
Figure Global Biomarker Research Services Revenue (Millions USD) and Growth Rate (2018-2025)
Table Biomarker Research Services Market Forecast by Regions (2018-2025)
Figure North America Biomarker Research Services Market Forecast (2018-2025)
Figure United States Biomarker Research Services Market Forecast (2018-2025)
Figure Canada Biomarker Research Services Market Forecast (2018-2025)
Figure Mexico Biomarker Research Services Market Forecast (2018-2025)
Figure Europe Biomarker Research Services Market Forecast (2018-2025)
Figure Germany Biomarker Research Services Market Forecast (2018-2025)
Figure France Biomarker Research Services Market Forecast (2018-2025)
Figure UK Biomarker Research Services Market Forecast (2018-2025)
Figure Russia Biomarker Research Services Market Forecast (2018-2025)
Figure Italy Biomarker Research Services Market Forecast (2018-2025)
Figure Rest of Europe Biomarker Research Services Market Forecast (2018-2025)
Figure Asia-Pacific Biomarker Research Services Market Forecast (2018-2025)
Figure China Biomarker Research Services Market Forecast (2018-2025)
Figure Japan Biomarker Research Services Market Forecast (2018-2025)
Figure Korea Biomarker Research Services Market Forecast (2018-2025)
Figure India Biomarker Research Services Market Forecast (2018-2025)
Figure Southeast Asia Biomarker Research Services Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Biomarker Research Services Market Forecast (2018-2025)
Figure South America Biomarker Research Services Market Forecast (2018-2025)
Figure Brazil Biomarker Research Services Market Forecast (2018-2025)
Figure Argentina Biomarker Research Services Market Forecast (2018-2025)
Figure Columbia Biomarker Research Services Market Forecast (2018-2025)
Figure Rest of South America Biomarker Research Services Market Forecast (2018-2025)
Figure Middle East and Africa Biomarker Research Services Market Forecast (2018-2025)
Figure Saudi Arabia Biomarker Research Services Market Forecast (2018-2025)
Figure United Arab Emirates Biomarker Research Services Market Forecast (2018-2025)
Figure Egypt Biomarker Research Services Market Forecast (2018-2025)
Figure Nigeria Biomarker Research Services Market Forecast (2018-2025)
Figure South Africa Biomarker Research Services Market Forecast (2018-2025)
Figure Turkey Biomarker Research Services Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Biomarker Research Services Market Forecast (2018-2025)
Figure Global Biomarker Research Services Forecast by Service Type (2018-2025)
Figure Global Biomarker Research Services Market Share Forecast by Service Type (2018-2025)
Figure Global Biomarker Research Services Forecast by Service Type (2018-2025)
Figure Global Biomarker Research Services Forecast by Therapeutic Area (2018-2025)
Figure Global Biomarker Research Services Market Share Forecast by Therapeutic Area (2018-2025)
Figure Global Biomarker Research Services Forecast by Therapeutic Area (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|